Meridian Bioscience Participates in Piper Sandler 32nd Annual Virtual Healthcare Conference

Rhea-AI Summary

Meridian Bioscience, Inc. (NASDAQ: VIVO) participated in the Piper Sandler 32nd Annual Virtual Healthcare Conference. A pre-recorded fireside chat featuring CEO Jack Kenny and CFO Bryan Baldasare was held on November 17, 2020. Investors can register for access to this chat via the Company's Investor Relations website, with recordings available until February 15, 2021. Meridian develops and distributes innovative diagnostic products for various applications, focusing on delivering accurate and rapid solutions in healthcare diagnostics globally.

Positive

• Participation in Piper Sandler Healthcare Conference may enhance visibility and investor interest.
• Access to recorded fireside chat provides ongoing investor engagement opportunities.

Negative

• None.

CINCINNATI, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today its participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief Financial Officer pre-recorded a fireside chat on Tuesday, November 17, 2020.

To register for access to the pre-recorded fireside chat, go to the Events & Presentations section of the Company’s Investor Relations website at https://investor.meridianbioscience.com/ and follow the link provided for the event. The recording will be available until February 15, 2021.

About Meridian Bioscience, Inc.
Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.

Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com.

Contact:
Charlie Wood
Vice President – Investor Relations
Meridian Bioscience, Inc.
Phone: +1 513.271.3700
Email: mbi@meridianbioscience.com

FAQ

What is the focus of Meridian Bioscience, Inc. as outlined in the press release?

Meridian focuses on developing and distributing innovative diagnostic products for various applications, especially in healthcare diagnostics.

When was the pre-recorded fireside chat with Meridian's executives released?

The fireside chat was released on November 17, 2020.

How can investors access Meridian's fireside chat?

Investors can access the fireside chat by registering on the Company's Investor Relations website.

What is the stock symbol for Meridian Bioscience, Inc.?

The stock symbol for Meridian Bioscience, Inc. is VIVO.

Until when will the recorded fireside chat be available for investors?

The recorded fireside chat will be available until February 15, 2021.